22 May 2019
DynamX Bioadaptor, the new frontier beyond stenting for PCI
Sponsored by Elixir Medical Corporation
Chairpersons:
D.J. Kereiakes, M. Leon
Summary
Consult this session on DynamX Bioadaptor to learn more about its technological advances and the early clinical trial results including QCA, IVUS and OCT imaging.
Learning Objectives
- To understand the technological advances of the DynamX Bioadaptor
- To be informed of the early clinical trial results including QCA, IVUS and OCT imaging
- To learn about the future directions and clinical trial plans for the DynamX Bioadaptor
